Domeyer-Klenske discusses mifepristone case on WUWM’s Lake Effect

On June 1, UW Ob-Gyn Division of Academic Specialists in Ob-Gyn Director Amy Domeyer-Klenske, MD, joined the WUWM show Lake Effect to talk about legal challenges to mifepristone and how they could affect health care in Wisconsin.

In the interview, Domeyer-Klenske provided background about mifepristone and its uses, discussed the current landscape of abortion care in Wisconsin, and the possible impact of federal cases related to mifepristone on quality of care:

“I don’t think anyone would want their family member receiving cancer care or receiving blood pressure medication, no one would choose the second-best medication when they’re offered an option that’s better. So I think in terms of our provision of health care to pregnant individuals, I would hope that when taking that into consideration when we’re thinking about these decisions in the legislature, and the judiciary, and the FDA, I hope all of folks who are caring for pregnant individuals are having these decisions, are considering that.

Pregnant individuals, like anyone else, want the best level of care. And right now the data shows that mifepristone is the most effective for these treatments and we don’t want to go to a situation where we need to use the second best treatment.”

Listen to the whole interview on Apple PodcastsSpotify, or